[REGN] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
06-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -58.12%
YoY- -64.98%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 1,828,200 2,169,500 2,048,400 1,933,700 1,711,800 1,927,800 1,663,496 6.49%
PBT 668,600 889,800 768,500 224,700 546,100 676,200 635,861 3.40%
Tax 44,000 97,800 98,900 31,600 85,000 -144,200 41,206 4.46%
NP 624,600 792,000 669,600 193,100 461,100 820,400 594,655 3.32%
Tax Rate -6.58% -10.99% -12.87% -14.06% -15.56% 21.33% -6.48% -
Total Cost 1,203,600 1,377,500 1,378,800 1,740,600 1,250,700 1,107,400 1,068,841 8.23%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin 34.16 36.51 32.69 9.99 26.94 42.56 35.75 -2.98%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS 5.69 7.25 6.12 1.77 4.23 7.58 5.51 2.16%
EPS Diluted 5.43 6.93 5.86 1.68 3.99 7.15 5.17 3.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.